TENAX THERAPEUTICS (TENX) CFO files Form 3 showing zero Common Stock owned
Rhea-AI Filing Summary
TENAX THERAPEUTICS, INC. filed an initial ownership report for Chief Financial Officer Thomas R. Staab II on Form 3. The filing lists his position in the company’s Common Stock as zero shares owned directly following the reported date, establishing a baseline of reported insider holdings.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
STAAB THOMAS R II
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 0 shares (Direct)
Key Figures
Common Stock held after date: 0.0000 shares
Holding entries: 1 entry
Unknown transaction code entries: 1 entry
3 metrics
Common Stock held after date
0.0000 shares
Total shares of Common Stock owned directly following transaction date
Holding entries
1 entry
Number of holding-type records in this Form 3
Unknown transaction code entries
1 entry
Transactions classified with unknown code in transaction summary
Key Terms
Form 3, Common Stock, beneficial ownership
3 terms
Form 3 regulatory
"filed an initial ownership report for Chief Financial Officer Thomas R. Staab II on Form 3"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
Common Stock financial
"The filing lists his position in the company’s Common Stock as zero shares"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
beneficial ownership regulatory
"The filing records his initial beneficial ownership position in the company’s Common Stock"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the TENX Form 3 filing for Thomas R. Staab II show?
The Form 3 shows that Chief Financial Officer Thomas R. Staab II reported initial ownership of 0 shares of TENAX THERAPEUTICS Common Stock. This establishes his baseline reported holdings as of the filing’s reported date for future comparison with later insider filings.
Who is the reporting person in the TENX Form 3 filing?
The reporting person is Thomas R. Staab II, the Chief Financial Officer of TENAX THERAPEUTICS, INC. The filing records his initial beneficial ownership position in the company’s Common Stock for U.S. securities law reporting purposes.
Does the TENX Form 3 show any insider buying or selling activity?
No insider buying or selling is indicated. The transaction is classified as a holding entry with an unknown transaction code and zero shares reported. It simply records that total Common Stock held directly after the reported date is 0.0000 shares.
What type of security is covered in the TENX Form 3 for the CFO?
The Form 3 covers Common Stock of TENAX THERAPEUTICS, INC. It reports the number of shares owned following the reported date, which in this case is 0.0000 shares held directly by the Chief Financial Officer.